Article Text

Download PDFPDF

Statistics from


Fuccio L, Minardi ME, Zagari RM, . Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007;147:553–62.

It is recommended in the US and Europe recommend a proton pump inhibitor with clarithromycin and either amoxicillin or metronidazole for the first-line eradication of Helicobacter pylori. There is a transatlantic divide in the duration of treatment, with recommendations from the US being 10 days and Europe 7 days. Furthermore, previous meta-analyses have suggested there is a clinically significant increase in eradication rate if triple therapy is given for 14 days rather than 7 days. Fuccio et al report an updated meta-analysis that identified 11 eligible studies comparing 7 days with 10 days of triple therapy in 1982 patients positive for H pylori. There was a statistically significant increase in eradication rate with 10 days of treatment (relative risk (RR) 1.05; 95% CI 1.01 to 1.10). Similarly, they identified 13 trials comparing 7 days with 14 days of triple therapy in 2849 patients and found a statistically significant increase in eradication if the duration of treatment was extended (RR 1.07; 95% CI 1.03 to 1.12). The authors stated that the increase in eradication rate, while statistically significant, was of doubtful clinical significance. The European recommendation of 7 days of triple …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.